Eiger BioPharmaceuticals, Inc. announced the appointment of Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs. Dr. Mannebach has more than 30 years of experience in the pharmaceutical industry in leadership roles including Parke-Davis, Warner Lambert, Pharmacia, Baxter, and Pfizer. Dr. Mannebach brings extensive global regulatory experience in the development of branded and specialty pharmaceuticals and biologics, including orphan designated products, with global regulatory authority interactions across multiple therapeutic areas leading to over 20 product approvals in his career. Dr. Mannebach spent most of the last decade as Vice President of Global Regulatory Affairs and as a member of the Executive Management Team at Covidien and Mallinckrodt Pharmaceuticals. Dr. Mannebach was most recently Vice President of Global Regulatory Affairs and Quality Assurance at Charleston Laboratories where he was a member of the executive team and responsible for global regulatory strategy as well as developing technical requirements of supply and quality management.